1873 — VIVA Biotech Holdings Balance Sheet
0.000.00%
Last trade - 00:00
- HK$799.44m
- HK$1.74bn
- CNY2.16bn
- 50
- 75
- 15
- 42
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 934 | 2,358 | 801 | 679 | 1,036 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 138 | 403 | 532 | 505 | 488 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 1,094 | 3,352 | 1,984 | 1,939 | 2,031 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 157 | 737 | 1,724 | 1,937 | 1,655 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 1,899 | 8,154 | 8,045 | 7,921 | 7,450 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 73 | 736 | 927 | 2,673 | 1,534 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 121 | 4,397 | 4,131 | 4,316 | 3,762 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 1,777 | 3,757 | 3,913 | 3,605 | 3,688 |
Total Liabilities & Shareholders' Equity | 1,899 | 8,154 | 8,045 | 7,921 | 7,450 |
Total Common Shares Outstanding |